Kwang Tai Medicinal Co., Ltd. Q4 2025 EPS NT$8.22
NQ Score
60/100
N1 Content Completeness
3
AI Summary (NQ-processed)
Kwang Tai Medicinal Co., Ltd. reported Q4 2025 earnings per share (EPS) of NT$8.22, with revenue of NT$10.252 billion and net profit after tax of NT$1.861 billion.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is Kwang Tai Medicinal's stock code?
- A: Kwang Tai Medicinal's stock code is 1707.
- Q: What industry does Kwang Tai Medicinal operate in?
- A: Kwang Tai Medicinal operates in the biotechnology and healthcare industry.
- Q: What was Kwang Tai Medicinal's revenue in Q4 2025?
- A: Kwang Tai Medicinal's revenue in Q4 2025 was NT$10.252 billion.
- Q: What was Kwang Tai Medicinal's net profit after tax in Q4 2025?
- A: Kwang Tai Medicinal's net profit after tax in Q4 2025 was NT$1.861 billion.